Literature DB >> 8238023

The biology of angiotensin II receptors.

K E Bernstein1, B C Berk.   

Abstract

Angiotensin II is very important in the regulation of blood pressure. This small peptide binds to cell surface receptors, initiating a wide diversity of physiologic responses. There are two major subtypes of angiotensin II receptors referred to as AT1 and AT2. In this article we describe the cloning and the biochemical characterization of the AT1 receptor. Antibodies against this receptor have been used to define its tissue distribution. The AT1 receptor is a member of the seven transmembrane spanning class of receptors. It initiates a complex series of signaling events, including activation of membrane phospholipases and intracellular kinases. In the human a single AT1 receptor protein mediates virtually all the effects of angiotensin II, suggesting that tissue specificity of angiotensin II must be due to organ-specific intracellular signaling.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238023     DOI: 10.1016/s0272-6386(12)80441-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

Review 1.  Angiotensin II: biosynthesis, molecular recognition, and signal transduction.

Authors:  J F Riordan
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

2.  The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.

Authors:  C R Esther; E M Marino; T E Howard; A Machaud; P Corvol; M R Capecchi; K E Bernstein
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

3.  Murine AGM single-cell profiling identifies a continuum of hemogenic endothelium differentiation marked by ACE.

Authors:  Muhammad Zaki Hidayatullah Fadlullah; Wen Hao Neo; Michael Lie-A-Ling; Roshana Thambyrajah; Rahima Patel; Renaud Mevel; Irène Aksoy; Nam Do Khoa; Pierre Savatier; Laura Fontenille; Syed Murtuza Baker; Magnus Rattray; Valerie Kouskoff; Georges Lacaud
Journal:  Blood       Date:  2022-01-20       Impact factor: 25.476

4.  Dependence of agonist activation on a conserved apolar residue in the third intracellular loop of the AT1 angiotensin receptor.

Authors:  L Hunyady; M Zhang; G Jagadeesh; M Bor; T Balla; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 5.  Newer approaches to genetic modeling in mice: tissue-specific protein expression as studied using angiotensin-converting enzyme (ACE).

Authors:  Hong D Xiao; Sebastien Fuchs; Kristen Frenzel; Justin M Cole; Kenneth E Bernstein
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

6.  Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects.

Authors:  Manuel Haschke; Manfred Schuster; Marko Poglitsch; Hans Loibner; Marc Salzberg; Marcel Bruggisser; Joseph Penninger; Stephan Krähenbühl
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

7.  Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice.

Authors:  H A Rockman; D J Choi; N U Rahman; S A Akhter; R J Lefkowitz; W J Koch
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Renin-angiotensin system polymorphisms in Taiwanese primary vesicoureteral reflux.

Authors:  Kuo-Pao Liu; Ching-Yuang Lin; Han-Jou Chen; Chou-Fu Wei; Guey-Jen Lee-Chen
Journal:  Pediatr Nephrol       Date:  2004-03-26       Impact factor: 3.714

Review 9.  Mediators of fibrosis and apoptosis in obstructive uropathies.

Authors:  Rosalia Misseri; Kirstan K Meldrum
Journal:  Curr Urol Rep       Date:  2005-03       Impact factor: 2.862

10.  Simultaneous determination of losartan, losartan acid and amlodipine in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.

Authors:  Vijaya Kumari Karra; Nageswara Rao Pilli; Jaswanth Kumar Inamadugu; J V L N Seshagiri Rao
Journal:  Pharm Methods       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.